Breaks Categories: News

WednesdayApr 17, 2024 3:38 pm

NetworkNewsBreaks – BizCann Expo Colombia to Showcase Insights on Emerging Trends in Canna-Business Landscape

The BizCann Expo, produced and hosted by ZJ Events, today announced the next rendition of its premier cannabis confab. Set to take place at the sleek Plaza Mayor in Medellin, Colombia, from May 18-19, the expo follows a series of blowout events in both North and South America. BizCann Expo is among the world’s elite business and networking events, leading industry innovation, entrepreneurship and education across all aspects of the cannabis industry. BizCann Expo provides novices as well as established players in the canna-business arena the ideal platform to elevate ventures and services in this burgeoning sector. This year’s event…

Continue Reading

WednesdayApr 17, 2024 3:32 pm

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Paving Way for Safer, More Efficient Autonomous Vehicles in Japan

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision solutions, today announced its receipt of a notice of allowance from the Japan Patent Office for its patent application, number 2020-557022, for the company’s “multi-spectral vehicular system for providing pre-collision alerts.” The patented technology combines data from pairs of stereoscopic infrared sensors and stereoscopic visible-light sensors through an advanced fusion module that enables precise obstacle detection and distance estimation. “We believe that the patent approval in Japan is a significant advancement for Foresight, paving the way for safer and more efficient autonomous vehicles in a country known for…

Continue Reading

WednesdayApr 17, 2024 3:26 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) to Launch Referral Partner Program

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, has announced the launch of its Sekur Referral Program for existing users and business referral partners. The goal of the program is to increase sales and reduce customer acquisition costs as the company embarks on its road to profitability. “We are very excited to launch our Sekur Referral Program for professionals and existing Sekur users. Sekur users are very passionate about their privacy, and we have received many requests for such a program. We believe this will accelerate sales, reduce costs of customer…

Continue Reading

WednesdayApr 17, 2024 3:16 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida

SOBRsafe (NASDAQ: SOBR), providers of next-generation, transdermal alcohol-detection solutions, has signed a hardware/software agreement with a four-facility behavioral health provider in Florida; this agreement is one of sixteen new accounts that SOBRsafe has signed in Q1 2024. According to the announcement, SOBRsafe’s SOBRcheck(TM) will replace breathalyzers for frontline screening and allow expanded monitoring abilities for the health provider, which provides a full continuum of care, from inpatient detoxification and residential treatment to outpatient services. The announcement noted that the provider has already installed SOBRcheck in each of its four facilities. “The customer historically used breathalyzers for select check-ins but felt…

Continue Reading

WednesdayApr 17, 2024 2:58 pm

NetworkNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) Announces Enhanced Features of 2024 Lucid Air Grand Touring Model

Lucid Group (NASDAQ: LCID), a company setting new standards for the luxury electric experience with the Lucid Air, America's most awarded new luxury vehicle, has released details about its 2024 Lucid Air Grand Touring. This year’s model features enhancements designed to help people drive farther and charge faster in a broader range of environments and conditions. Enhanced features include an EPA-estimated range of 516 miles, the longest range of any EV in the U.S. market today; more efficiency and more sustainable performance, thanks to the vehicle’s proprietary motor design, battery cell chemistry and thermal characteristics; and an estimated 15%–30% faster…

Continue Reading

WednesdayApr 17, 2024 2:52 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M

Longeveron (NASDAQ: LGVN) is a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. The company today announced its entry into definitive agreements for the exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its Class A common stock having an exercise price of $2.35 per share, originally issued in October 2023 and April 2024. Gross proceeds to Longeveron from the exercise of the existing warrants are expected to be approximately $6.2 million, prior to deducting placement agent fees and…

Continue Reading

WednesdayApr 17, 2024 2:46 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Expansion of Investigative Pipeline

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company today announced the expansion of its pipeline into metabolic and related disorders including weight loss and liver health. FSD Pharma has initiated investigations into certain ingredients and combinations of ingredients that show promise in improving liver health, reducing metabolic disease and reducing visceral fat. The company is leading these efforts to potentially create a new exciting product line in addition to unbuzzd(TM). To view the full press release, visit https://nnw.fm/Qe4Y2 About FSD Pharma Inc. FSD is…

Continue Reading

WednesdayApr 17, 2024 2:16 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., announced that results from a phase 2 Visionary-MS long-term extension (“LTE”) study have been presented at the 2024 American Academy of Neurology (“AAN”) annual meeting. The data, which demonstrates improved clinical, functional and structural outcomes associated with daily oral dosing of CNM-Au8 30 mg. for up to three years of treatment, was presented by Dr. Michael Barnett, MBBS, FRACP, FRCP, PhD, from the University of Sydney. The new long-term results from the clinical trial indicate the repair and remyelinating effects of CNM-Au8 treatment in…

Continue Reading

WednesdayApr 17, 2024 1:42 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has received an urgent request from the Ministry of Health (“MOH”) of Malawi requesting emergency access to IV suramin. According to the announcement, Malawi officials requested the suramin in efforts to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used in that region of Africa; the drug is used specifically to treat the most severe form of African sleeping sickness. Last week, PaxMedica completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin) in preparation for a future…

Continue Reading

WednesdayApr 17, 2024 1:06 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project

  Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has filed an independent technical report for its PCH ionic adsorption clay (“IAC”) project located in Goiás, Brazil. The PCH MRE report was prepared in accordance with National Instrument 43-10 (“NI 43-101”). Titled “Technical Report on the Maiden Mineral Resource Estimate for the PCH Project, State of Goiás, Brazil,” the report indicated no material differences from results disclosed in the company’s press release released last month. The company noted that the report was coauthored by independent…

Continue Reading